Tuesday, August 18, 2009
Amgen's Vectibix Meets Goal In Colon Cancer Study - Visit Bulgaria
Visit Bulgaria
Amgen's Vectibix Meets Goal In Colon person Study
Visit Bulgaria
... from the studies module be presented at an upcoming medical conference in Europe, feat Amgen shares to rise 5-cents to $59.89 in after-hours trading.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment